176 related articles for article (PubMed ID: 38473963)
1. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
2. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.
Egusquiza-Alvarez CA; Robles-Flores M
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1831-1854. PubMed ID: 35441886
[TBL] [Abstract][Full Text] [Related]
3. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
Matsumoto K; Bay BH
Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells.
Egusquiza-Alvarez CA; Castañeda-Patlán MC; Albarran-Gutierrez S; Gonzalez-Aguilar H; Moreno-Londoño AP; Maldonado V; Melendez-Zajgla J; Robles-Flores M
Front Oncol; 2021; 11():642940. PubMed ID: 34136383
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.
McGee AM; Douglas DL; Liang Y; Hyder SM; Baines CP
Cell Cycle; 2011 Dec; 10(23):4119-27. PubMed ID: 22101277
[TBL] [Abstract][Full Text] [Related]
6. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
[TBL] [Abstract][Full Text] [Related]
7. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis.
Sünderhauf A; Hicken M; Schlichting H; Skibbe K; Ragab M; Raschdorf A; Hirose M; Schäffler H; Bokemeyer A; Bettenworth D; Savitt AG; Perner S; Ibrahim S; Peerschke EI; Ghebrehiwet B; Derer S; Sina C
Cell Mol Gastroenterol Hepatol; 2021; 12(1):229-250. PubMed ID: 33515804
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production.
Hu M; Li HM; Bogoyevitch MA; Jans DA
Biochem Biophys Res Commun; 2017 Aug; 489(4):460-465. PubMed ID: 28576489
[TBL] [Abstract][Full Text] [Related]
9. Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune function.
Tian H; Wang G; Wang Q; Zhang B; Jiang G; Li H; Chai D; Fang L; Wang M; Zheng J
Cancer Sci; 2022 Mar; 113(3):875-890. PubMed ID: 34978120
[TBL] [Abstract][Full Text] [Related]
10. A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.
Yenugonda V; Nomura N; Kouznetsova V; Tsigelny I; Fogal V; Nurmemmedov E; Kesari S; Babic I
J Transl Med; 2017 Oct; 15(1):210. PubMed ID: 29047383
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte-specific loss of mitochondrial p32/C1qbp causes cardiomyopathy and activates stress responses.
Saito T; Uchiumi T; Yagi M; Amamoto R; Setoyama D; Matsushima Y; Kang D
Cardiovasc Res; 2017 Aug; 113(10):1173-1185. PubMed ID: 28498888
[TBL] [Abstract][Full Text] [Related]
12. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway.
Wu H; Chu Y; Sun S; Li G; Xu S; Zhang X; Jiang Y; Gao S; Wang Q; Zhang J; Pang D
Front Cell Dev Biol; 2021; 9():607142. PubMed ID: 33708767
[TBL] [Abstract][Full Text] [Related]
14. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival.
Hu M; Crawford SA; Henstridge DC; Ng IH; Boey EJ; Xu Y; Febbraio MA; Jans DA; Bogoyevitch MA
Biochem J; 2013 Aug; 453(3):381-91. PubMed ID: 23692256
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.
Fogal V; Richardson AD; Karmali PP; Scheffler IE; Smith JW; Ruoslahti E
Mol Cell Biol; 2010 Mar; 30(6):1303-18. PubMed ID: 20100866
[TBL] [Abstract][Full Text] [Related]
16. Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.
Feichtinger RG; Oláhová M; Kishita Y; Garone C; Kremer LS; Yagi M; Uchiumi T; Jourdain AA; Thompson K; D'Souza AR; Kopajtich R; Alston CL; Koch J; Sperl W; Mastantuono E; Strom TM; Wortmann SB; Meitinger T; Pierre G; Chinnery PF; Chrzanowska-Lightowlers ZM; Lightowlers RN; DiMauro S; Calvo SE; Mootha VK; Moggio M; Sciacco M; Comi GP; Ronchi D; Murayama K; Ohtake A; Rebelo-Guiomar P; Kohda M; Kang D; Mayr JA; Taylor RW; Okazaki Y; Minczuk M; Prokisch H
Am J Hum Genet; 2017 Oct; 101(4):525-538. PubMed ID: 28942965
[TBL] [Abstract][Full Text] [Related]
17. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
18. gC1qR: A New Target for Cancer Immunotherapy.
Lei Y; Li X; Qin D; Zhang Y; Wang Y
Front Immunol; 2023; 14():1095943. PubMed ID: 36776869
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous
Raschdorf A; Sünderhauf A; Skibbe K; Ghebrehiwet B; Peerschke EI; Sina C; Derer S
Front Oncol; 2020; 10():631592. PubMed ID: 33628739
[TBL] [Abstract][Full Text] [Related]
20. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription.
Li K; Gao B; Li J; Chen H; Li Y; Wei Y; Gong D; Gao J; Zhang J; Tan W; Wen T; Zhang L; Huang L; Xiang R; Lin P; Wei Y
Oncotarget; 2015 Nov; 6(35):38107-26. PubMed ID: 26497555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
